Compounds > edotreotide
Page last updated: 2024-09-04

edotreotide and Multiple Endocrine Neoplasia Type 1

edotreotide has been researched along with Multiple Endocrine Neoplasia Type 1 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Albers, MB; Apitzsch, JC; Bartsch, DK; Bollmann, C; Kann, PH; Librizzi, D; Lopez, CL; Manoharan, J; Slater, EP1

Other Studies

1 other study(ies) available for edotreotide and Multiple Endocrine Neoplasia Type 1

ArticleYear
Limited Value of Ga-68-DOTATOC-PET-CT in Routine Screening of Patients with Multiple Endocrine Neoplasia Type 1.
    World journal of surgery, 2017, Volume: 41, Issue:6

    Topics: Adult; Aged; Female; Humans; Male; Middle Aged; Multiple Endocrine Neoplasia Type 1; Octreotide; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals

2017